Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study.

M.M Tielemans; M.G.H. van Oijen; C.J. Mulder; K.J. Vos; W.F. Lems

Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study.

Translated title of the contribution: Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study.

M.M Tielemans, M.G.H. van Oijen, C.J. Mulder, K.J. Vos, W.F. Lems

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study.
Original language	Undefined/Unknown
Pages (from-to)	281-287
Number of pages	7
Journal	European Journal of Gastroenterology and Hepatology
Volume	24
Publication status	Published - 2012

Cite this

@article{52d0ed5f98db4d18a0e036fb8c6ef5cc,

title = "Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study.",

author = "M.M Tielemans and {van Oijen}, M.G.H. and C.J. Mulder and K.J. Vos and W.F. Lems",

year = "2012",

language = "Undefined/Unknown",

volume = "24",

pages = "281--287",

journal = "European Journal of Gastroenterology and Hepatology",

issn = "0954-691X",

publisher = "Lippincott Williams & Wilkins",

}

Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study. / Tielemans, M.M; van Oijen, M.G.H.; Mulder, C.J. et al.
In: European Journal of Gastroenterology and Hepatology, Vol. 24, 2012, p. 281-287.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Esomeprazole relieves upper gastrointestinal symptoms in high-risk and averaga-risk NSAID users in daily clinical practice: results from an open-label study.

AU - Tielemans, M.M

AU - van Oijen, M.G.H.

AU - Mulder, C.J.

AU - Vos, K.J.

AU - Lems, W.F.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0954-691X

VL - 24

SP - 281

EP - 287

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

ER -